Royalty Pharma plc
NASDAQ:RPRX
32.77 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 1,330.813 | 1,700.088 | 230.064 | 1,241.201 | 1,701.954 | 2,461.419 | 1,517.855 | 1,343.18 |
| Depreciation & Amortization
| 0 | 0 | 5.67 | 22.996 | 23.058 | 23.924 | 33.267 | 33.267 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 2.344 | 2.357 | 2.17 | 2.443 | 5.428 | 0 | 0 | 0 |
| Change In Working Capital
| 53.383 | 5.382 | 32.662 | -16.322 | 75.966 | -24.671 | -1,562.379 | -1,475.619 |
| Accounts Receivables
| -4.551 | -1.521 | -4.744 | -29.143 | -0.4 | 159.861 | 111.529 | -84.48 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -2.29 | 6.236 | 2.286 | -4.586 | -0.766 | 6.496 | 1.35 | 0 |
| Other Working Capital
| 60.224 | 0.667 | 35.12 | 17.407 | 77.132 | -191.028 | -1,675.258 | -1,391.139 |
| Other Non Cash Items
| 1,382.446 | 1,279.975 | 1,873.414 | 767.218 | 228.223 | -793.433 | 1,629.574 | 1,517.485 |
| Operating Cash Flow
| 2,768.986 | 2,987.802 | 2,143.98 | 2,017.536 | 2,034.629 | 1,667.239 | 1,618.317 | 1,418.313 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| -10.955 | -12.542 | -9.896 | -34.855 | -40.155 | -27.042 | -24.173 | -2 |
| Purchases Of Investments
| -2,736.201 | -2,115.522 | -2,565.068 | -3,593.656 | -3,937.529 | -2,751.653 | -422.403 | -2,300.707 |
| Sales Maturities Of Investments
| 118.361 | 25.831 | 1,545.543 | 1,776.308 | 1,203.28 | 875.07 | 750 | 600 |
| Other Investing Activites
| -49.32 | 29.444 | 0 | -18.077 | 15.084 | -250 | 0 | 115 |
| Investing Cash Flow
| -2,678.115 | -2,072.789 | -1,029.421 | -1,870.28 | -2,759.32 | -2,153.625 | 303.424 | -1,587.707 |
| Financing Activities: | ||||||||
| Debt Repayment
| 1,471.235 | -1,000 | 0 | 1,272.533 | 680.634 | -294 | -294 | 907 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 1,908.744 | 0 | 0 | 0 |
| Common Stock Repurchased
| -229.651 | -304.759 | 0 | 0 | 0 | -4.266 | 0 | 0 |
| Dividends Paid
| -376.465 | -358.327 | -333.322 | -285.184 | -397.843 | -739.276 | -814.359 | -735.174 |
| Other Financing Activities
| -503.974 | -485.668 | -611.534 | -602.237 | -704.363 | -154.084 | -270.742 | -295.08 |
| Financing Cash Flow
| 361.145 | -2,148.754 | -944.856 | 385.112 | 1,487.172 | -1,191.626 | -1,379.101 | -123.254 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 452.016 | -1,233.741 | 169.703 | 532.368 | 762.481 | -1,678.012 | 542.64 | -292.648 |
| Cash At End Of Period
| 929.026 | 477.01 | 1,710.751 | 1,541.048 | 1,008.68 | 246.199 | 1,924.211 | 1,381.571 |